State Of Wyoming Stoke Therapeutics, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$10.36 - $23.93 $9,002 - $20,795	-869 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$17.19 - $26.1 $5,019 - $7,621	292 Added 50.61%	869 $18,000
Q4 2021 Feb 11, 2022	BUY	$18.11 - $30.72 $1,738 - $2,949	96 Added 19.96%	577 $14,000
Q3 2021 Feb 11, 2022	SELL	$23.65 - $34.44 $7,047 - $10,263	-298 Reduced 38.25%	481 $12,000
Q2 2021 Feb 11, 2022	BUY	$30.53 - $41.09 $13,860 - $18,654	454 Added 139.69%	779 $26,000
Q1 2021 Feb 08, 2022	BUY	$36.08 - $69.81 $11,726 - $22,688	325 New	325 $13,000

125

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $386M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.